Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Prospective Evaluation of the Performance and Safety of the Ellipse PRECICE Intramedullary Limb Lengthening System

NCT01601301 is registered in ClinicalTrials.gov with Ellipse Technologies, Inc. as lead sponsor.

NCT NCT01601301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01601301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Prospective Evaluation of the Performance and Safety of the Ellipse PRECICE Intramedullary Limb Lengthening System
Lead sponsor
Ellipse Technologies, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2012
Completion date
June 30, 2018
Enrollment
32 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

limb length discrepancy